ALK alterations such as increased ALK copy number, gene amplification and translocation have been shown to be present in 80 % of inflammatory breast cancer and 25 % of triple-negative breast cancers (TNBC), which are considered to be the most aggressive subtypes of breast cancers [21–23]. This evidence concerns the gene ALK and inflammatory breast carcinoma.